Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Billionaire Mark Walter set to become majority owner of the Los Angeles Lakers in a record-breaking $10 billion deal.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Billionaire Mark Walter set to become majority owner of the Los Angeles Lakers in a record-breaking $10 billion deal.